Beneficial effects of fingolimod in MS patients with high serum Sema4A levels
Beneficial effects of fingolimod in MS patients with high serum Sema4A levels
About this item
Full title
Author / Creator
Publisher
United States: Public Library of Science
Journal title
Language
English
Formats
Publication information
Publisher
United States: Public Library of Science
Subjects
More information
Scope and Contents
Contents
We previously demonstrated that patients with multiple sclerosis (MS) of high serum Sema4A levels are resistant to IFN-β therapy. To further elucidate the role of serum Sema4A as a biomarker for therapeutic stratification in MS patients, it is important to clarify the efficacy of other disease-modifying drugs (DMD) in those with high serum Sema4A l...
Alternative Titles
Full title
Beneficial effects of fingolimod in MS patients with high serum Sema4A levels
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_plos_journals_2012014891
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2012014891
Other Identifiers
ISSN
1932-6203
E-ISSN
1932-6203
DOI
10.1371/journal.pone.0193986
